Single registrationBuy Now
Capital expenditures represent some of the most expensive decisions a business will ever make, including equipment, relocation, outsourcing, mergers and acquisitions. Building a business case that clearly outlines the purpose, costs, benefits, risks, and opportunities of the decision is critical to making a sound decision.
Why should you attend ?
You want a new piece of equipment. A major competitor just went on the block and you wonder whether you should buy them. How do you decide? And what about the financing – should you lease the equipment or finance the purchase with debt or equity or some combination? One misstep and your career could be in jeopardy. All of these questions can be answered with standardized financial forecasting models.
Description of the topic:
Join us to learn about the latest and most accurate methods for performing capital expenditure (CAPEX) analyses. Learn how to establish your hurdle rate (minimum acceptable rate of return) for your CAPEX projects and which metric most fairly represents the true expected rate of return on your projects. Receive our standardized CAPEX model for use in performing future analyses.
Areas Covered in the Session:
Who will benefit:
Physical CD-DVD of recorded session will be despatched after 72 hrs on completion of payment
Miles Hutchinson is a CGMA and experienced businessman. He has been an auditor with PriceWaterhouseCoopers and the chief financial officer of a $1 billion real estate development company. Mr. Hutchinson is a professional speaker and consultant who has presented over 2,000 seminars and training sessions on myriad business and financial topics, like financial analysis and modeling, accounting, strategic planning, and compliance with the Sarbanes-Oxley Act. He is recognized as an expert in payroll, and sales and use tax as well as financial modeling and analysis, business strategy and communications.
He is the author of several useful accounting and tax tools. His clients include Abbott Labs, Bank of America, Boston Scientific, Citicorp, Corning, the FBI, the FDA, the Federal Reserve, GE, Pfizer, Siemens, US Marine Corps, and the US Army.